- Home
- KLTOW vs COO Comparison
KLTOW vs COO Comparison
Compare KLTOW & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KLTOW | COO |
|---|---|---|
| Founded | N/A | 1980 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 16.1B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | KLTOW | COO |
|---|---|---|
| Price | $0.11 | $82.52 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $88.55 |
| AVG Volume (30 Days) | N/A | ★ 3.3M |
| Earning Date | N/A | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.87 |
| Revenue | N/A | ★ $4,092,400,000.00 |
| Revenue This Year | N/A | $6.56 |
| Revenue Next Year | N/A | $5.32 |
| P/E Ratio | ★ N/A | $44.18 |
| Revenue Growth | N/A | ★ 5.06 |
| 52 Week Low | N/A | $61.78 |
| 52 Week High | N/A | $100.24 |
Technical Indicators
Market Signals| Indicator | KLTOW | COO |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 63.62 |
| Support Level | $0.10 | $81.92 |
| Resistance Level | $0.15 | $83.64 |
| Average True Range (ATR) | 0.02 | 1.74 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 70.60 | 74.03 |
Price Performance
Historical ComparisonAbout KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.